|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Departments of Pharmacy, School of Pharmacy, University of North Carolina at Chapel Hill
2 From the Department of Pharmacy, Duke University Medical Center
3 From the Division of Allergy, Critical Care, and Pulmonary Medicine, Duke University Medical Center
Certain antibiotics, particularly piperacillin, have been reported to be associated with a high incidence of allergic reactions in patients with cystic fibrosis. We initiated a study to determine the relative frequency of allergic reactions, ie, drug-induced fever and rash, to parenteral beta-lactam antibiotics in adult patients with cystic fibrosis. Charts of 111 patients were reviewed for each hospitalization to assess allergic reactions. Of 90 evaluable patients, 26 patients developed one or more allergic reactions to beta-lactam antibiotics. The number of allergic reactions per number of patients receiving specific antibiotics were carbenicillin (4/56), mezlocillin (7/42), piperacillin (11/31), ticarcillin (1/20), cefazolin (0/24), ceftazidime (1/35), imipenem/cilastatin (4/16), and nafcillin (3/36). The mean time to onset of drug-induced fever or of rash was 9.1 days. As a group penicillins had a higher frequency of allergic reactions than cephalosporins. The frequency of reactions was greatest with acylaminopenicillins (mezlocillin and piperacillin) and imipenem/cilastatin. The results of this study indicate that in addition to piperacillin, mezlocillin and imipenem/cilastatin may be associated with a high incidence of allergic reactions in patients with CF.
Key Words: acylaminopenicillins carboxypenicillins cephalosporins cystic fibrosis drug allergy imipenem/cilastatin
Submitted on February 22, 1993
Accepted on February 9, 1994
This article has been cited by other articles:
![]() |
J S Parmar and S Nasser Antibiotic allergy in cystic fibrosis Thorax, June 1, 2005; 60(6): 517 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Thickett, M. J. Wildman, C. D. Fegan, and D. E. Stableforth Haemolytic anaemia following treatment with piperacillin in a patient with cysticfibrosis J. Antimicrob. Chemother., March 1, 1999; 43(3): 435 - 436. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |